欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SI/H/0100/001
药品名称Rawel SR 1,5 mg filmsko oblozene tablete s podaljsanim sproscanjem
活性成分
    • indapamide 1500.0 µg
剂型Prolonged-release film-coated tablet
上市许可持有人KRKA, d.d., Smarjeska cesta 6, Novo mesto, Slovenia
参考成员国 - 产品名称Slovenia (SI)
互认成员国 - 产品名称
    • Poland (PL)
      RAWEL SR
    • Latvia (LV)
      Rawel SR 1,5 mg ilgstošas darbības apvalkotās tabletes
    • Lithuania (LT)
      Rawel SR 1,5 mg pailginto atpalaidavimo tabletės
    • Estonia (EE)
      Rawel SR
    • Hungary (HU)
      Rawel SR 1,5 mg retard filmtabletta
    • Czechia (CZ)
      RAWEL SR
    • Slovakia (SK)
      RAWEL SR
许可日期2005/08/04
最近更新日期2023/07/13
药物ATC编码
    • C03BA11 indapamide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic [Article 10.1.(a)(iii), first paragraph]
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase